Search

everythinglearnresearchcommunity

for

Search:↓

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

A group has developed therapies that show promise for treating cancer and various other conditions.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Asparagus racemosus and Withania somnifera can help reduce side effects of a cancer drug.

A lotion with natural extracts significantly sped up hair growth in women with hair loss from chemotherapy.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Adding a second method to PROTACs could improve cancer treatment.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Scalp cooling prevented hair loss in half of the patients, despite significant side effects.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Cooler scalp temperatures during chemotherapy may prevent hair loss.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Vitamin E in the diet might help protect against hair loss caused by the chemotherapy drug doxorubicin in rabbits.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Indigofera tinctoria leaf extract has many compounds that support its traditional medicinal uses.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

PLD is an effective and safer alternative for treating breast cancer.